BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Keyser JL, Poupaert JH, Dumont P. Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. J Pharm Sci. 1991;80:67-70. [PMID: 2013853 DOI: 10.1002/jps.2600800117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Gèze A, Chau LT, Choisnard L, Mathieu J, Marti-batlle D, Riou L, Putaux J, Wouessidjewe D. Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres. International Journal of Pharmaceutics 2007;344:135-42. [DOI: 10.1016/j.ijpharm.2007.06.050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
2 Shah RB, Khan MA. Nanopharmaceuticals: Challenges and Regulatory Perspective. In: de Villiers MM, Aramwit P, Kwon GS, editors. Nanotechnology in Drug Delivery. New York: Springer; 2009. pp. 621-46. [DOI: 10.1007/978-0-387-77668-2_21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 François G, Katz JL. Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulisification as an alternative to ultrasonic and high-shear devices. Chemphyschem 2005;6:209-16. [PMID: 15751338 DOI: 10.1002/cphc.200400527] [Cited by in Crossref: 273] [Cited by in F6Publishing: 162] [Article Influence: 18.2] [Reference Citation Analysis]
4 Yi YM, Yang TY, Pan WM. Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles. World J Gastroenterol 1999;5:57-60. [PMID: 11819388 DOI: 10.3748/wjg.v5.i1.57] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
5 Le Visage C, Quaglia F, Dreux M, Ounnar S, Breton P, Bru N, Couvreur P, Fattal E. Novel microparticulate system made of poly(methylidene malonate 2.1.2). Biomaterials 2001;22:2229-38. [DOI: 10.1016/s0142-9612(00)00411-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Rubas W, Grass GM. Gastrointestinal lymphatic absorption of peptides and proteins. Advanced Drug Delivery Reviews 1991;7:15-69. [DOI: 10.1016/0169-409x(91)90047-g] [Cited by in Crossref: 25] [Article Influence: 0.8] [Reference Citation Analysis]
7 Le Ray A, Vert M, Gautier J, Benoǐt J. End‐Chain Radiolabeling and in Vitro Stability Studies of Radiolabeled Poly(hydroxy acid) Nanoparticles. Journal of Pharmaceutical Sciences 1994;83:845-51. [DOI: 10.1002/jps.2600830618] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lambert G, Fattal E, Couvreur P. Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv Drug Deliv Rev 2001;47:99-112. [PMID: 11251248 DOI: 10.1016/s0169-409x(00)00116-2] [Cited by in Crossref: 119] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
9 Breton P, Roy D, Marchal-heussler L, Seguin C, Couvreur P, Lescure F. New Poly(Methylidene Malonate 2.1.2) Nanoparticles: Recent Developments. In: Gregoriadis G, Mccormack B, Poste G, editors. Targeting of Drugs 4. Boston: Springer US; 1994. pp. 161-72. [DOI: 10.1007/978-1-4899-1207-7_15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 Fattal E, Labarre D, Vauthier C. From Polymer Chemistry and Physicochemistry to Nanoparticulate Drug Carrier Design and Applications. In: Yaszemski M, Trantolo D, Lewandrows ki K, Hasirci V, Altobelli D, Wise D, editors. Tissue Engineering And Novel Delivery Systems. CRC Press; 2003. [DOI: 10.1201/9780203913338.ch26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006;23:1417-50. [PMID: 16779701 DOI: 10.1007/s11095-006-0284-8] [Cited by in Crossref: 596] [Cited by in F6Publishing: 418] [Article Influence: 39.7] [Reference Citation Analysis]
12 Lescure F, Seguin C, Breton P, Bourrinet P, Roy D, Couvreur P. Preparation and characterization of novel poly(methylidene malonate 2.1.2.)-made nanoparticles. Pharm Res 1994;11:1270-7. [PMID: 7816755 DOI: 10.1023/a:1018986226557] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
13 Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20. [PMID: 11166403 DOI: 10.1016/s0168-3659(00)00339-4] [Cited by in Crossref: 2283] [Cited by in F6Publishing: 350] [Article Influence: 114.2] [Reference Citation Analysis]
14 Le Ray A, Vert M, Gautier J, Benoît J. Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. International Journal of Pharmaceutics 1994;106:201-11. [DOI: 10.1016/0378-5173(94)90003-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
15 Le Visage C, Couvreur P, Mysiakine E, Breton P, Bru N, Fattal E. In vitro and in vivo Evaluation of Poly(Methylidene Malonate 2.1.2) Microparticles Behavior for Oral Administration. Journal of Drug Targeting 2010;9:141-53. [DOI: 10.3109/10611860108997924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shinoda T, Maeda A, Kojima S, Kagatani S, Konno Y, Sonobe T, Akaike T. Nanosphere Coated with Lactosyl-Polystyrene Polymer as a Targeting Carrier to Hepatocytes. Drug Delivery 2008;6:147-51. [DOI: 10.1080/107175499266896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Fattal E, Hillaireau H, Mura S, Nicolas J, Tsapis N. Targeted Delivery Using Biodegradable Polymeric Nanoparticles. In: Siepmann J, Siegel RA, Rathbone MJ, editors. Fundamentals and Applications of Controlled Release Drug Delivery. Boston: Springer US; 2012. pp. 255-88. [DOI: 10.1007/978-1-4614-0881-9_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Labhasetwar V, Song C, Levy RJ. Nanoparticle drug delivery system for restenosis. Advanced Drug Delivery Reviews 1997;24:63-85. [DOI: 10.1016/s0169-409x(96)00483-8] [Cited by in Crossref: 109] [Article Influence: 4.5] [Reference Citation Analysis]